Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Brain Neoplasms × trametinib × Clear all

Phase

Status

Active not recruiting 3 Terminated 2 Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1 CNS 1

Conditions

Thyroid Carcinoma, Anaplastic 3 Melanoma 3 Glioma 3 Recurrence 2 Neoplasm Metastasis 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Solid Tumor Cancer 1 Solid Tumor 1 Skin Neoplasms 1 Sexual Dysfunction, Physiological 1 Refractory Differentiated Thyroid Gland Carcinoma 1 Rare Malignant Neoplasm 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neurofibromatosis 1 1 Neoplasms 1 Multiple Myeloma 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Locally Advanced Thyroid Gland Carcinoma 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia 1 Hematologic Neoplasms 1 Eunuchism 1 Erectile Dysfunction 1

Interventions

Radiosurgery 23 Magnetic Resonance Spectroscopy 18 pembrolizumab 10 Temozolomide 10 Specimen Handling 8 Bevacizumab 8 Radiotherapy 5 Nivolumab 5 Magnetic Resonance Imaging 5 Ipilimumab 5 Cyclophosphamide 5 Neuropsychological Tests 4 Carboplatin 4 Capecitabine 4 fludarabine 3 fluciclovine F-18 3 encorafenib 3 abemaciclib 3 Radiation 3 Proton Therapy 3 Mental Status and Dementia Tests 3 Etoposide 3 Dexamethasone 3 Blood Specimen Collection 3 Adrenal Cortex Hormones 3 trastuzumab deruxtecan 2 osimertinib 2 niraparib 2 binimetinib 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03563729 2023-07-13

MEMBRAINS

Herlev Hospital

Phase 2 Recruiting

CNSDermatologic

Brain Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡